Gennex Laboratories Ltd
company logo

Gennex Laboratories Ltd

Gennex Lab. Share Price

Pharmaceuticals
Small Cap

-

0 (0%)

Invest in Gennex Laboratories Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions

Gennex Laboratories Ltd Performance

-

-

-

-


-

-

-

-

-

Gennex Laboratories Ltd Fundamentals

Read More

436.93Cr

25.28

2.50

0.03

0.76

0%

7.68

Gennex Laboratories Ltd Financials

Gennex Laboratories Ltd Financialsright-arrow

Gennex Laboratories Ltd Shareholding Pattern

Gennex Laboratories Ltd Delivery and Volume

About Gennex Laboratories Ltd

Gennex Laboratories Limited (formerly Prudential Pharmaceuticals Limited) was incorporated on June 25, 1985. The Company got converted into a Public Limited Company and the name was changed from Prudential Pharmaceuticals Limited to Gennex Laboratories Limited in 2007. The Company is one of the l

Arihant Baid

1990

-

NameDesignation
Y Ravinder ReddyIndependent Director
Arihant BaidChairman & Managing Director
T M GopalaKrishnanWhole-time Director
Sadhana BhansaliIndependent Director
A S Nageswar RaoIndependent Director
A Ranga Rao PantuluIndependent Director
Mohammed Khaleequr RahmanAdditional Director
News and Events...

Similar Stocks

What's Trending

View All
View All

Gennex Laboratories Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Gennex Laboratories Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Gennex Laboratories Ltd's share price is ₹19.21 as of 2024-11-24.
Gennex Laboratories Ltd's P/E ratio is 25.28 times as of 2024-11-24.
Gennex Laboratories Ltd's most recent financial reports indicate a price-to-book ratio of 2.5, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Gennex Laboratories Ltd's market capitalization is ₹436.93 Cr as on 2024-11-24.
The current financial records of Gennex Laboratories Ltd show a 9.45% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Gennex Laboratories Ltd's most recent financial filings, the company has a total asset value of ₹179.22, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Gennex Laboratories Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Gennex Laboratories Ltd's 52-week high and low as of 2024-11-24 are ₹19.42 and ₹18.75, respectively.